PDB25 COST-EFFECTIVENESS OF INSULIN DEGLUDEC/ASPART VERSUS BIPHASIC INSULIN ASPART IN PATIENTS WITH TYPE 2 DIABETES IN IRAN
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.907
https://www.valueinhealthjournal.com/article/S1098-3015(19)33285-1/fulltext
Title :
PDB25 COST-EFFECTIVENESS OF INSULIN DEGLUDEC/ASPART VERSUS BIPHASIC INSULIN ASPART IN PATIENTS WITH TYPE 2 DIABETES IN IRAN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33285-1&doi=10.1016/j.jval.2019.09.907
First page :
Section Title :
Open access? :
No
Section Order :
10799